抑制 CSF-1R 和 IL-6R 可防止 cDC2s 转化为免疫无能的肿瘤诱导 DC3s,从而增强 DC 驱动的治疗潜力
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential.
肿瘤细胞治疗研究
ALL SOURCES
把在研试验和前沿论文合在一起看,按时间倒序排列。本页条数 = 前沿论文 + 临床试验两块之和(导航里的「临床试验」板块只收在招的那部分,不另计入)。
Inhibition of CSF-1R and IL-6R prevents conversion of cDC2s into immune incompetent tumor-induced DC3s boosting DC-driven therapy potential.
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。